HOME » ABOUT US » COMPANY PROFILE
|
MISSION STATEMENT The mission of Nexomics Biosciences is to give our customers a competitive-advantage in the drug discovery process using know how and intellectual property developed by a large scale structural genomics project. We will accomplish this mission by delivering high-quality protein products and high-resolution 3D structures. We also seek to provide a challenging and satisfying work environment for our talented staff of scientists. CORPORATE OVERVIEW Nexomics Biosciences focuses on the discovery, development and commercialization of novel drugs focusing on cancer, antiviral and antibiotic treatments. Additionally, Nexomics Biosciences functions as a contract research organization (CRO), offering a broad array of gene-to-structure services to the biopharmaceutical community. By utilizing our fully integrated drug discovery pipeline we can offer a variety of services from bioinformatics target profiling, genetic cloning, recombinant protein expression, laboratory-scale fermentation, crystallization, NMR structural studies, Xray crystallographic structural studies, and functional annotation. Nexomics Biosciences aims to build a portfolio of intellectual property associated with structure-based assay development, protein production and drug discovery. Our long term goal is development of a proprietary pharmaceutical discovery program based on characterizing disease related proteins and their molecular functions, and by identifying potential drug target binding compounds. |